Invention Grant
US08008450B2 Therapeutic use of anti-CS1 antibodies 有权
抗CS1抗体的治疗用途

Therapeutic use of anti-CS1 antibodies
Abstract:
The present invention is directed to antagonists of CS1 that bind to and neutralize at least one biological activity of CS1. The invention also includes a pharmaceutical composition comprising such antibodies or antigen-binding fragments thereof. The present invention also provides for a method of preventing or treating disease states, including autoimmune disorders and cancer, in a subject in need thereof, comprising administering into said subject an effective amount of such antagonists.
Public/Granted literature
Information query
Patent Agency Ranking
0/0